Bayer’s Lynkuet™ (elinzanetant) approved in the U.S. for treatment of moderate to severe vasomotor symptoms due to menopause
Berlin, October 24, 2025 – Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved…